Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. C J Mugglestone*, Independent consultant to pharmaceutical industry *From 1974 to 1987 C J Mugglestone worked on hormone replacement therapy projects and in postmenopausal osteoporosis with Organon, Schering Chemicals, and Brocades. Since 1987 he has worked as an independent consultant on projects that have included hormone replacement therapy.
  1. C J M Medical, Sutton, Surrey SM2 5JG

    EDITOR,--I am confused over how Klim McPherson reaches some of his conclusions, particularly the conclusion that long term use of hormonal supplements in postmenopausal women may be responsible for an average net loss of years of life.1 Far more studies have been done that show benefits of hormone replacement therapy on coronary heart disease and osteoporosis than that show benefits on breast cancer. The figures for coronary heart disease, of a 50% reduction in overall mortality,2 and the preventability of osteoporosis and fractures are reasonably believable.3 The studies …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular